Search - Université Clermont Auvergne Access content directly

Filter your results

79 Results
Structure: Internal structure identifier : 1063706

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells

Marc Berger , Benjamin Lebecque , Thomas Tassin , Louis-Thomas Dannus , Juliette Berger et al.
Scientific Reports, 2021, 11 (1), ⟨10.1038/s41598-021-85734-0⟩
Journal articles hal-03278034v1

Réforme de l’accès dérogatoire aux médicaments

Jacques-Olivier Bay
Bulletin du Cancer, 2022, 109 (1), pp.20-22. ⟨10.1016/j.bulcan.2021.11.008⟩
Journal articles hal-03737555v1

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

Jean‐baptiste Bossard , Jean‐baptiste Beuscart , Marie Robin , Mohamad Mohty , Fiorenza Barraco et al.
American Journal of Hematology, 2021, 96 (1), pp.80-88. ⟨10.1002/ajh.26034⟩
Journal articles hal-03089653v1

Characterization of the novel HLA‐B *56:76 allele by sequencing‐based typing

Lucie Blandin , Jonathan Visentin , Gwendaline Guidicelli , Paul Rouzaire , Richard Lemal et al.
HLA: Immune Response Genetics, 2021, 98 (1), pp.66-67. ⟨10.1111/tan.14237⟩
Journal articles hal-03449232v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin Parry , Ignaty Leshchiner , Romain Guièze , Connor Johnson , Eugen Tausch et al.
Nature Medicine, 2023, 29 (1), pp.158-169. ⟨10.1038/s41591-022-02113-6⟩
Journal articles hal-03950358v1

Response to vaccination against SARS‐CoV ‐2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study

Olivier Tournilhac
British Journal of Haematology, 2022, 197 (4), pp.424-427. ⟨10.1111/bjh.18055⟩
Journal articles hal-03737660v1

Characterization of the novel HLA‐DQA1 *05:01:07 allele by sequencing‐based typing

Lucie Blandin , Mamy Ralazamahaleo , Gwendaline Guidicelli , Paul Rouzaire , Richard Lemal et al.
HLA: Immune Response Genetics, 2021, ⟨10.1111/tan.14484⟩
Journal articles hal-03443769v1

Corrigendum to ‘Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers’

G. Fossard , F. Broussais , I. Coelho , S. Bailly , E. Nicolas-Virelizier et al.
Annals of Oncology, 2021, 32 (7), pp.945. ⟨10.1016/j.annonc.2021.04.021⟩
Journal articles hal-03440923v1

Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)

Jacques-Olivier Bay
Bone Marrow Transplantation, 2022, 57 (1), pp.125-127. ⟨10.1038/s41409-021-01477-6⟩
Journal articles hal-03737639v1

COVID-19 lockdown and mental health: why we must look into oncology units

Jacques-Olivier Bay
Psychological Medicine, 2022, 52 (4), pp.787-788. ⟨10.1017/S0033291720002500⟩
Journal articles hal-03737570v1

Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial

Marc G Berger
Journal articles hal-03737540v1

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients

Rafik Haderbache , Walid Warda , Eric Hervouet , Mathieu Neto da Rocha , Rim Trad et al.
Journal of Translational Medicine, 2021, 19 (1), ⟨10.1186/s12967-021-02925-z⟩
Journal articles hal-03443941v1

Rationale for the combination of venetoclax and ibrutinib in Tprolymphocytic leukemia

Christoph Kornauth , Charles Herbaux , Bernd Boidol , Chantal Guillemette , Patrick Caron et al.
Journal articles hal-03440893v1

A bicellular fluorescent ductal carcinoma in situ (DCIS)-like tumoroid to study the progression of carcinoma: practical approaches and optimization

Ola Habanjar , Anne-Catherine Maurin , Cyrielle Vituret , Caroline Vachias , Lucie Longechamp et al.
Biomaterials Science, 2023, 11 (9), pp.3308-3320. ⟨10.1039/d2bm01470j⟩
Journal articles hal-04103734v1

Impact du microenvironnement inflammatoire et de l'obésité dans la transition du cancer canalaire in situ (CCIS) en carcinome invasif (CCI) via le développement d’un modèle 3D de tumoroïdes fluorescents hétérogènes

Ola Habanjar , Anne-Catherine Maurin , Cyrielle Vituret , Lucie Longechamp , Cecile Garnier et al.
Journée jeunes chercheurs du réseau NACRE, Jun 2022, Paris, France
Conference papers hal-03853902v1

Characterization of the novel HLA‐C *05:01:58 allele by sequencing‐based typing

Lucie Blandin , Gwendaline Guidicelli , Laura Blouin , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 98 (2), pp.170-171. ⟨10.1111/tan.14303⟩
Journal articles hal-03449041v1

Characterization of the novel HLA‐B *14:01:13 allele by sequencing‐based typing

Lucie Blandin , Jonathan Visentin , Gwendaline Guidicelli , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 98 (2), pp.155-156. ⟨10.1111/tan.14304⟩
Journal articles hal-03449051v1

Applicability of the long‐term uncertainty in measurement ( LTUM ) method for analytical performance assessment in clinical cytometry laboratories

Marc Berger , Céline Bourgne
Cytometry Part B: Clinical Cytometry, 2022, 102 (3), pp.254-260. ⟨10.1002/cyto.b.22050⟩
Journal articles hal-03737689v1

Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

Olivier Tournilhac
Bone Marrow Transplantation, 2021, 56 (3), pp.692-695. ⟨10.1038/s41409-020-01013-y⟩
Journal articles hal-03737669v1

Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study

Johannes Schetelig , Jennifer Hoek , Stephan Stilgenbauer , Jan Moritz Middeke , Niels Smedegaard Andersen et al.
Bone Marrow Transplantation, 2021, ⟨10.1038/s41409-021-01524-2⟩
Journal articles hal-03440366v1

Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate TM Trial

Judith Trotman , Christian Buske , Alessandra Tedeschi , Jeffrey Matous , David Macdonald et al.
Clinical Cancer Research, 2021, 27 (21), pp.5793-5800. ⟨10.1158/1078-0432.CCR-21-1497⟩
Journal articles hal-03440467v1

Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL

M. van Gelder , O. Tournilhac , D. Te Raa , H.P.J. Visser
Annals of Oncology, 2021, 32 (11), pp.1442-1443. ⟨10.1016/j.annonc.2021.08.1990⟩
Journal articles hal-03440402v1
Image document

Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study

Marie Selvy , Nicolas Kerckhove , Bruno Pereira , Fantine Barreau , Daniel Nguyen et al.
Frontiers in Pharmacology, 2021, 12, ⟨10.3389/fphar.2021.637593⟩
Journal articles hal-03238418v1
Image document

A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease

Christine Serratrice , Jérôme Stirnemann , Amina Berrahal , Nadia Belmatoug , Fabrice Camou et al.
Journal of Clinical Medicine, 2020, 9 (8), pp.2343. ⟨10.3390/jcm9082343⟩
Journal articles hal-02935598v1

No Detectable Alteration of Inorganic Allogeneic Bone Matrix Colonizing Mesenchymal Cells: A Step Towards Personalized Bone Grafts

Roger Erivan , Nicolas Samper , Guillaume Villatte , Stéphane Boisgard , Stéphane Descamps et al.
Journal of Bone Metabolism, 2021, 28 (2), pp.161-169. ⟨10.11005/jbm.2021.28.2.161⟩
Journal articles hal-03280648v1

DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model

Benjamin Lebecque , Céline Bourgne , Véronique Vidal , Marc Berger
Cancers, 2021, 13 (14), pp.3587. ⟨10.3390/cancers13143587⟩
Journal articles hal-03440088v1

Characterization of the novel HLA‐DQA1 *01:39 allele by next‐generation sequencing

Steve Genebrier , Paul Rouzaire , Emeric Texeraud , Gerald Bertrand , Virginie Renac et al.
HLA: Immune Response Genetics, 2021, 98 (3), pp.240-241. ⟨10.1111/tan.14142⟩
Journal articles hal-03449390v1

Characterization of the novel HLA‐C *06:311 allele by sequencing‐based typing

Lucie Blandin , Mamy Ralazamahaleo , Marine Cargou , Richard Lemal , Paul Rouzaire et al.
HLA: Immune Response Genetics, 2021, 97 (6), pp.565-566. ⟨10.1111/tan.14233⟩
Journal articles hal-03449287v1

ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome

Camilla Lemvigh , Erin Michelle Parry , Stephanie Deng , Nathan Dangle , Neil Ruthen et al.
Blood, 2022, 140 (Supplement 1), pp.1807-1808. ⟨10.1182/blood-2022-162550⟩
Journal articles hal-03950370v1